0
0
11/15/23 at 9:20am
Organization
Médecins Sans Frontières (MSF) International
38 words
0
Comments
The results of the endTB clinical trial offers multiple new shortened drug regimens to treat adults and children with multidrug-resistant tuberculosis.
You are the first to view
https://www.msf.org/landmark-clinical-trial-redefines-multidrug-resistant-tb-treatment-options
Create an account
or login to join the discussion